CVS Health Corp vs Gold Fields Limited — how do they compare? CVS Health Corp trades at $93.68 (market cap $122.36B), while Gold Fields Limited trades at $40.84 (market cap $36.72B). The key difference: CVS Health Corp is far larger — about 3.3× Gold Fields Limited's market cap, and Gold Fields Limited pays the higher dividend (5.64%). Which is the better fit depends on your goals.
| CVS | GFI | |
|---|---|---|
Market Cap | $122.36B | $36.72B |
Sector | Health | Basic Materials |
52-Week High | $110.60 | $61.52 |
52-Week Low | $65.51 | $29.31 |
Enterprise Value | $184.71B | $38.16B |
Dividend Yield | 2.78% | 5.64% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Gold Fields (GFI) trades at $40.82, up 9.32% in 24 hours, reflecting strong momentum near recent highs. The stock shows a bullish technical signal with moving averages supporting upward trends, though RSI levels indicate potential overbought conditions. Fundamentally, GFI exhibits robust profitability with a 40.76% net income margin and attractive valuation metrics, including a P/E of 10.36. Recent earnings have been mixed, with a Q1 2025 beat but subsequent misses, while 2025 revenue is projected to surge to $8.8B. Institutional interest is evident with Allspring Global increasing its stake by 62.3% in Q1 2026 (SEC filing, 2026-07-18).
The outlook for GFI is positive, driven by strong gold prices and operational growth, with a consensus price target of $52.00 offering ~27% upside. Risks include cost inflation, geopolitical factors affecting mining operations, and volatile cash flows from heavy investing activities. Analyst sentiment is cautiously optimistic with 44% buy ratings, but investors should monitor execution on earnings targets and debt levels, which rose to 25.01% of assets in 2024.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is primarily involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Read more on GFI →